I established MICRO DOC® Consultants in April 1992. Providing expert microbiology consulting services to various pharmaceutical and clinical research companies: (1) selection and evaluation of preclinical antibacterial candidates and design of development studies; (2) advice and assistance in the preparation of regulatory documents for the FDA and foreign regulatory filings, IE microbiology sections of INDs, NDAs, and MAAs; (3) attendance at scientific meetings and preparation of reports on the properties and status of new antiinfective drugs in development; (4) preparation of scientific papers on new antiinfective agents, (5) review antibacterial test data in patent applications and define their relevance and validity.

Participated in writing Microbiology Section and Package Insert for the following antibiotics that have achieved FDA approval: sparfloxacin, fosfomycin tromethamine, tobramycin for inhalation, grepafloxacin, cefdinr, and rabeprazole/clarithromycin/amoxicillin.

Previously Director of Infectious Disease Research at a major pharmaceutical company. Holder of BSP, MS, and PhD degrees.